• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_LASSO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_LASSO Back to Search Results
Catalog Number UNK_LASSO
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stenosis (2263)
Event Date 08/31/2002
Event Type  Injury  
Manufacturer Narrative
Manufacturer's ref.No: (b)(4).No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Biosense webster manufacturer's report number: 2029046-2020-01233 is related to the same incident.
 
Event Description
This complaint is from a literature source.The following complications were reported in this publication: it was reported that 12 patients underwent catheter ablation of atrial fibrillation and suffered pulmonary vein stenosis (moderate).Intervention was not reported.There are 0 death events and 0 device malfunctions reported in this publication.Model and catalog number are not available, but the suspected device is lasso.Other biosense webster devices that were also used in this study: none non-biosense webster devices that were also used in this study: chilli publication details title: use of intracardiac echocardiography for prediction of chronic pulmonary vein stenosis after ablation of atrial fibrillation objective: measurement of pv flows with ice before and after ablation has been proposed as a method for predicting which patients will develop chronic pv stenosis.However, this hypothesis has never been tested.Methods: consecutive patients who were referred to our laboratory for af ablation procedures were included in the study.Antiarrhythmic drugs and warfarin were discontinued five half-lives and 3 days before the ablation, respectively.Amiodarone was withdrawn 4 to 5 months before the procedure.For patients who presented in af on the day of the study, a transesophageal echocardiogram was done immediately before the ablation to exclude the presence of thrombus in the left atrium.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_LASSO
Type of Device
UNK
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key10532887
MDR Text Key206933579
Report Number2029046-2020-01232
Device Sequence Number1
Product Code DRF
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 08/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_LASSO
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/24/2020
Initial Date FDA Received09/14/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
-
-